May 22, 2023 7:00am EDT NeuBase Announces Positive Preclinical Data Supporting the Capabilities of Stealth Editors™
May 11, 2023 4:15pm EDT NeuBase Reports Business Update and Financial Results for the First Quarter of 2023
May 02, 2023 5:00pm EDT NeuBase Therapeutics Selected to Present Two Oral Presentations at the American Society of Gene & Cell Therapy (ASGCT) 2023 Annual Meeting
Feb 14, 2023 4:10pm EST NeuBase Therapeutics Reports Business Update and Financial Results for the First Quarter of Fiscal Year 2023
Dec 21, 2022 8:00am EST NeuBase Therapeutics Reports Business Update and Financial Results for Fiscal Year 2022
Oct 21, 2022 8:00am EDT NeuBase Therapeutics Announces Gene Editing Research Agreement with Global Healthcare Company
Oct 14, 2022 4:05pm EDT NeuBase Therapeutics Announces Strategic Restructuring Focused on Advancing Its Platform in Gene Editing